Horizon Space Acquisition II Corp. (HSPT)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.36	0.65	-
Cash & Short-Term Investments	0.36	0.65	-
Prepaid Expenses	0.12	0.07	-
Total Current Assets	0.49	0.72	-
Other Long-Term Assets	70.07	69.34	-
Total Assets	70.56	70.06	-
Other Current Liabilities	0.29	0.27	0
Total Current Liabilities	0.29	0.27	0
Total Liabilities	70.36	0.27	0
Common Stock	0	69.34	0
Additional Paid-In Capital	-	0.31	0.02
Retained Earnings	0.2	0.14	-0
Comprehensive Income & Other	-	-	-0.03
Shareholders' Equity	0.2	69.8	-0
Total Liabilities & Equity	70.56	70.06	-
Net Cash (Debt)	0.36	0.65	-
Net Cash Per Share	0.08	0.25	-
Filing Date Shares Outstanding	9.08	9.08	1.5
Total Common Shares Outstanding	9.08	9.08	1.5
Working Capital	0.2	0.45	-0
Book Value Per Share	0.02	7.69	-0.00
Tangible Book Value	0.2	69.8	-0
Tangible Book Value Per Share	0.02	7.69	-0.00

Updated Dec 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q